Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial
Yingwei Liu1, Nina Ghosh, Girish Dwivedi
1Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Background:
It has been shown that (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is useful in identifying inflamed plaque in major arteries. This study evaluated the feasibility of inflamed plaque detection with routinely acquired cardiac FDG-PET viability studies in patients with severe coronary artery disease and left ventricular dysfunction.
Methods:
Clinically indicated myocardial viability scans using FDG and PET combined with computed tomography from 103 patients were retrospectively analyzed for FDG uptake in the proximal, ascending, and descending thoracic aorta. Aortic uptake was graded on the basis of peak and mean target-to-background ratio (TBR): grade 0, < 1; grade 1, 1.01-1.49; grade 2, 1.5-1.99; and grade 3, > 2.
Results:
Of the 103 patients, 71 (68.9%) had a history of myocardial infarction, 88 (85.4%) were on statins, and 70 (68%) were on angiotensin-converting enzyme (ACE) inhibitors. Increased FDG uptake (mean TBR grade 1-3) was seen in 79 of 103 patients (77%), and grade 3 aortic uptake based on peak TBR was found in 12 of 103 patients (12%).
Conclusions:
Detection of inflamed atherosclerotic plaque in the aorta with conventional FDG viability scans is feasible. The rate of very positive uptake in this population of ischemic heart disease patients is low, possibly reflecting aggressive secondary risk factor modification including statin and ACE inhibitor use.
Insights
Routine cardiac (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) scans can detect inflamed aortic plaque in patients with severe coronary artery disease. This feasibility study shows uptake in 77% of patients, with aggressive risk factor modification potentially lowering high uptake rates.
Area of Science:
- Cardiovascular Imaging
- Nuclear Medicine
- Atherosclerosis Research
Background:
- (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is established for identifying arterial inflammation.
- Cardiac FDG-PET viability studies are routinely performed in patients with severe coronary artery disease and left ventricular dysfunction.
Purpose of the Study:
- To evaluate the feasibility of detecting inflamed atherosclerotic plaque in the aorta using standard cardiac FDG-PET viability scans.
- To assess FDG uptake in the thoracic aorta in patients undergoing myocardial viability assessment.
Main Methods:
- Retrospective analysis of 103 clinically indicated myocardial viability scans (FDG-PET/CT).
- FDG uptake in the thoracic aorta was quantified using target-to-background ratio (TBR).
- Aortic uptake was graded based on peak and mean TBR values.
Main Results:
- 77% of patients (79/103) showed increased FDG uptake in the aorta (mean TBR grade 1-3).
- 12% of patients (12/103) exhibited grade 3 aortic uptake based on peak TBR.
- The study population had a high prevalence of cardiovascular risk factors and treatments (e.g., statins, ACE inhibitors).
Conclusions:
- Conventional FDG viability scans are feasible for detecting inflamed atherosclerotic plaque in the aorta.
- The observed low rate of very high aortic FDG uptake may be attributed to effective secondary risk factor management.
- These findings suggest a potential role for routine cardiac PET scans in assessing aortic inflammation in specific patient cohorts.
More Related Videos
09:43In vivo Near Infrared Fluorescence (NIRF) Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
Published on: August 4, 2011
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Imaging Studies for Cardiovascular System V: CT
Acute Coronary Syndrome III: Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)